Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Garver

Showing results (41-50 of 97) with videos related to

Pageof 10
Sort By:
Psychiatry Research|July 1, 1986
Relationship of psychotic symptom clusters in schizophrenia to neuroleptic treatment and growth hormone response to apomorphineF P Zemlan, J Hirschowitz, F Sautter, et al.
Psychiatry Research|May 1, 1984
Lithium response and psychoses: a double-blind, placebo-controlled studyD L Garver, J Hirschowitz, R Fleishmann, et al.
Psychiatry Research|July 1, 1986
Lithium ratio in vitro: familial patterns of illnessF J Sautter, R Hitzemann, J Griffin, et al.
Life Sciences|April 27, 1981
Kinetic analysis of platelet monoamine oxidase in chronic schizophreniaA Breier, R J Hitzemann, J Hirschowitz, et al.
The Journal of Clinical Psychiatry|September 1, 1984
Fluphenazine plasma levels and clinical responseM L Mavroidis, D R Kanter, J Hirschowitz, et al.
Psychopharmacology Bulletin|January 1, 1977
Growth hormone response and central aminergic systems in affective diseases [proceedins]D L Garver, G N Pandey, C Hengeveld, et al.
Psychopharmacology Bulletin|January 1, 1984
Therapeutic blood levels of fluphenazine: plasma or RBC determinations?M L Mavroidis, D R Kanter, J Hirschowitz, et al.
The American Journal of Psychiatry|April 1, 1991
Relation of CSF neurotensin concentrations to symptoms and drug response of psychotic patientsD L Garver, G Bissette, J K Yao, et al.
The American Journal of Psychiatry|November 1, 1985
Down-regulation of central dopamine receptors in schizophreniaF P Zemlan, R J Hitzemann, J Hirschowitz, et al.
Psychopharmacology Bulletin|January 1, 1985
Plasma haloperidol levels and clinical response: confounding variablesM L Mavroidis, D L Garver, D R Kanter, et al.
Pageof 10

Showing results (41-50 of 97) with videos related to

Sort By:
Pageof 10
Psychiatry Research|July 1, 1986
Relationship of psychotic symptom clusters in schizophrenia to neuroleptic treatment and growth hormone response to apomorphineF P Zemlan, J Hirschowitz, F Sautter, et al.
Psychiatry Research|May 1, 1984
Lithium response and psychoses: a double-blind, placebo-controlled studyD L Garver, J Hirschowitz, R Fleishmann, et al.
Psychiatry Research|July 1, 1986
Lithium ratio in vitro: familial patterns of illnessF J Sautter, R Hitzemann, J Griffin, et al.
Life Sciences|April 27, 1981
Kinetic analysis of platelet monoamine oxidase in chronic schizophreniaA Breier, R J Hitzemann, J Hirschowitz, et al.
The Journal of Clinical Psychiatry|September 1, 1984
Fluphenazine plasma levels and clinical responseM L Mavroidis, D R Kanter, J Hirschowitz, et al.
Psychopharmacology Bulletin|January 1, 1977
Growth hormone response and central aminergic systems in affective diseases [proceedins]D L Garver, G N Pandey, C Hengeveld, et al.
Psychopharmacology Bulletin|January 1, 1984
Therapeutic blood levels of fluphenazine: plasma or RBC determinations?M L Mavroidis, D R Kanter, J Hirschowitz, et al.
The American Journal of Psychiatry|April 1, 1991
Relation of CSF neurotensin concentrations to symptoms and drug response of psychotic patientsD L Garver, G Bissette, J K Yao, et al.
The American Journal of Psychiatry|November 1, 1985
Down-regulation of central dopamine receptors in schizophreniaF P Zemlan, R J Hitzemann, J Hirschowitz, et al.
Psychopharmacology Bulletin|January 1, 1985
Plasma haloperidol levels and clinical response: confounding variablesM L Mavroidis, D L Garver, D R Kanter, et al.
Pageof 10